8
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Urinary Excretion of Iohexol Administered Enterally in Rats with Intestinal Ischaemia a Transmural and Transperitoneal Route of Transport

Pages 751-754 | Received 22 Jan 1988, Accepted 19 Feb 1988, Published online: 08 Jul 2009
 

Abstract

Serum and urinary levels of iohexol (Omnipaque®) were evaluated in 20 rats with 1.5 ml of contrast medium injected into closed segments of ischaemic small bowel. Ten rats had the small intestine situated inside, and 10 rats outside, the peritoneal cavity. Radiographs were taken every hour, and blood and urine were sampled for testing at the end of the 4-h observation period. A marked increase in opacity of the urinary bladder was seen on radiographs during the observation period in the rats with the bowel laid inside the peritoneal cavity. Correspondingly high concentrations of iodine in the urine and serum were measured by the X-ray fluorescence technique. In comparison, the animals with the bowel placed outside the peritoneal cavity had only traces of contrast medium in serum and urine. These differences between the two groups of rats were highly significant (p < 0.001). The chief route of transport of contrast medium (>90% of the total absorption) was transmurally and trans-peritoneally from the lumen of ischaemic bowel to blood before subsequent excretion via the kidneys.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.